Scholars Central

Market analysisPublished 30 Mar 2021

World Congress and Expo on Cardio Health, March 2-4, 2021 Hanoi, Vietnam

Authors: Dr. Usaf Ibrahim

Atherosclerosis: Open Access

Volume 6 · Issue 2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The global Cardiovascular Drugs Market was valued approximately US$ 80.0 Bn in 2016 and is anticipated to register CAGR of over 1.0% from 2017 to 2025 to reach value of approximately US$ 91.0 Bn by 2025. Drug classes used to treat cardiovascular indications such as hyperlipidaemia, hypertension are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Atherosclerosis: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAtherosclerosis: Open Access
  • SubjectCardiology
  • BylineArticles whose byline prints “Dr. Usaf Ibrahim”